Browsing publications by Professor Graham Jackson

Newcastle AuthorsTitleYearFull text
Dr Laura Jardine
Dr Venetia Bigley
Dr Kim Pearce
Dr Alison Dickinson
Professor Graham Jackson
et al.
A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants2014
Dr Nicola Sunter
Professor Andy Hall
Dr Tryfonia Mainou-Fowler
Professor Graham Jackson
Dr James Allan
et al.
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia2014
Professor Graham Jackson
Minimal Residual Disease: What Are the Minimum Requirements? Reply2014
Professor Graham Jackson
Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results2014
Professor Graham Jackson
Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome2014
Kile Green
Dr Laura Jardine
Dr Kim Pearce
Dr Venetia Bigley
Professor Graham Jackson
et al.
Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study2013
Professor Graham Jackson
Biologically defined risk groups can be used to define the impact of thalidomide maintenance therapy in newly diagnosed multiple myeloma2013
Dr Christopher Bacon
Sarah Wilkinson
Dr Gavin Spickett
Dr Helen Lucraft
Professor Graham Jackson
et al.
Epstein-Barr virus-independent diffuse large B-cell lymphoma in DNA ligase 4 deficiency2013
Professor Graham Jackson
Long-term Follow-up of MRC Myeloma IX Trial: Survival Outcomes with Bisphosphonate and Thalidomide Treatment2013
Professor Graham Jackson
Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study2013
123456789101112131415161718